Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder (TRACT-RCT)

September 15, 2020 updated by: Sidse Arnfred, Psychiatric Research Unit, Region Zealand, Denmark

Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder: A Pragmatic, Multicenter Non-inferiority Randomized Controlled Trial

Transdiagnostic Cognitive Behavior Therapy (CBT) delivered in the individual format, have been proven just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) to make it applicable as group therapy in Danish Mental Health Service and a naturalistic trial of this manual has shown promising results. As the use of one manual instead of several diagnosis specific manuals in regional clinics could simplify logistics and reduce waiting time, the investigators want to compare group UP-CBT with diagnosis specific group CBT.

Method: A partial blinded, pragmatic, non-inferiority, multicentre randomized clinical trial (RCT). UP-CBT is compared to treatment-as-usual CT. 124 patients are included in each intervention arm, recruited from three Danish regional Mental Health Service Clinics. 31st July 2018 suppl: Inclusion number expanded to 170 in each arm due to unexpected large drop-out.

Study Overview

Detailed Description

Background: Transdiagnostic Cognitive Behavior Therapy (TCBT) Manuals delivered in individual format, have been reported to be just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) developed by Barlow and colleagues for use in Mental Health Service (MHS), and shown effects comparable to traditional CBT in a naturalistic trial. As the use of one manual instead of several diagnosis-specific manuals could simplify logistics, reduce waiting time, and increase therapist expertise compared to diagnosis specific CBT, the study aim to test the relative efficacy of group UP-CBT and diagnosis specific group CBT.

Methods/design: It is a partially blinded, pragmatic, non-inferiority, parallel, multi-center randomized controlled trial (RCT) of UP-CBT vs diagnosis specific CBT for depression, social anxiety disorder and agoraphobia/panic disorder. In both arms, the intervention consists of weekly group session for 14 weeks. In total, 248 patients are recruited from three regional MHS centers across the country and included in two intervention arms.31st July 2018 suppl: Inclusion number expanded to 340 due to unexpected large drop-out.

Outcomes are measured at end of therapy and at 6 months follow-up. Weekly patient-rated outcomes and group evaluations are collected for every session. Outcome assessors, blind to delivered intervention, will perform the observer-based symptom ratings, and fidelity assessors will monitor manual adherence.

Discussion: The current study will be the first RCT investigating the dissemination of the UP in a MHS setting and UP delivered in groups and including patients with depression. Hence the results are expected to add substantially to the evidence base for rational group psychotherapy in MHS. The planned moderator and mediator analyses could spur new hypotheses about mechanisms of change in psychotherapy and the association between patient characteristics and treatment effect.

Study Type

Interventional

Enrollment (Actual)

292

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region
      • Copenhagen, Capital Region, Denmark, 2200
        • Psychotherapeutic Unit, Mental Health Centre Copenhagen
    • Central Region
      • Risskov, Central Region, Denmark, 8240
        • Outpatient Clinic for Anxiety and Personality Disorders
      • Risskov, Central Region, Denmark, 8240
        • Outpatient Clinic for Mania and Depression
    • Region Zealand
      • Slagelse, Region Zealand, Denmark, 4200
        • Psychiatric Outpatient Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Referred to Danish Mental Health Service

  1. a principal DSM-5 diagnosis of Unipolar Depression (single episode or recurrent)(app. 50%), Social Anxiety Disorder (app. 25%), and Agoraphobia/Panic Disorder (app 25%)
  2. the patient is currently not using any antidepressants or use accepted antidepressants (according to predefined list), which have been unchanged for at least 4 weeks before inclusion and no change in antidepressants is anticipated,
  3. sufficient knowledge of the Danish language.

Exclusion Criteria:

  1. risk of suicide is high according to clinicians or assessment researchers
  2. alcohol or drug dependence,
  3. cluster A or B (DSM-5) personality disorder diagnosed by intake clinicians or assessment researcher,
  4. co-morbidity of pervasive developmental disorder, psychotic disorders, eating disorders, bipolar disorder, or severe physical illness,
  5. psychopharmacological treatment other than those predefined as acceptable,
  6. patient does not accept to stop the use of anxiolytics within the first four weeks of intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: UP-CBT
The "Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP) is one of the most widely studied transdiagnostic manuals. Here, the investigators apply a group manual that has been modified from the published UP for individual therapy based on recommendations on group delivery from the UP Institute (personal communications) and integrations modifications necessary for the delivery in the Mental Health Service. Group UP-CBT, consist of 8 treatment modules delivered in 14 group sessions given weekly in 2 hour sessions.
Psychotherapy in groups based on the "Unified Protocol" a third generation CBT-type psychotherapy
ACTIVE_COMPARATOR: Standard-CBT
Group CBT following Danish versions of diagnosis specific manuals (Social Anxiety Disorder (SAD) Group; Depression (DEP) Group; Agoraphobia/Panic Disorder (Ag/PD) (standard-CBT). The original elements of psychoeducation, cognitive restructuring, and exposure/activity scheduling are present in the applied manuals. Standard-CBT, consist of 8 treatment modules delivered in 14 group sessions given weekly in 2 hour sessions.
Psychotherapy in groups based on diagnosis specific, manualized, cognitive behavior therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WHO Well-Being Index (WHO-5)
Time Frame: Week 19 after allocation
Self-rating questionnaire, 5 items on positive quality of life, web-based
Week 19 after allocation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hopkins Symptom Check List (SCL-25)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Work and Social Adjustment Scale (WSAS)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Hamilton Depression Rating Scale (HDRS)
Time Frame: Week 19 after allocation
6-item HDRS based on telephone interview
Week 19 after allocation
Hamilton Anxiety Rating Scale (HARS)
Time Frame: Week 19 after allocation
6-item HARS based on telephone interview
Week 19 after allocation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: Weekly, weeks 4-19 after allocation, before session
Validated questionnaire
Weekly, weeks 4-19 after allocation, before session
Overall Depression Severity and Impairment Scale (ODSIS)
Time Frame: Weekly, weeks 4-19 after allocation, before session
Validated questionnaire
Weekly, weeks 4-19 after allocation, before session
WHO Well-Being Index (WHO-5)
Time Frame: Weekly, weeks 4-19 after allocation, before session
Validated questionnaire
Weekly, weeks 4-19 after allocation, before session
Positive Affect and Negative Affect Schedule (PANAS)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Positive Affect and Negative Affect Schedule (PANAS)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Hopkins Symptom Check List (SCL-25)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Emotion Regulation Questionnaire (ERQ)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Emotion Regulation Questionnaire (ERQ)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
WHO Well-Being Index (WHO-5)
Time Frame: Week 42-43 after allocation
Self-rating questionnaire, 5 items on positive quality of life, web-based
Week 42-43 after allocation
Emotion Regulation Strategies Questionnaire (ERSQ)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Emotion Regulation Strategies Questionnaire (ERSQ)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Perseverative Thinking Questionnaire (PTQ)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Perseverative Thinking Questionnaire (PTQ)
Time Frame: Week 42-43 after allocation
Validated questionnaires - web-based
Week 42-43 after allocation
Becks Depression inventory (BDI-II)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Becks Depression inventory (BDI-II)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Work and Social Adjustment Scale (WSAS)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Liebowitch Social Anxiety Scale (LSAS)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Liebowitch Social Anxiety Scale (LSAS)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Panic Disorder Severity Scale (PDSS)
Time Frame: Week19 after allocation
Validated questionnaire - web-based
Week19 after allocation
Panic Disorder Severity Scale (PDSS)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Mobility Inventory for Agoraphobia (MIA)
Time Frame: Week 19 after allocation
Validated questionnaire - web-based
Week 19 after allocation
Mobility Inventory for Agoraphobia (MIA)
Time Frame: Week 42-43 after allocation
Validated questionnaire - web-based
Week 42-43 after allocation
Hamilton Depression Rating Scale
Time Frame: Week 42-43 after allocation
6-item HDRS based on telephone interview
Week 42-43 after allocation
Hamilton Anxiety Rating Scale
Time Frame: Week 42-43 after allocation
6-item HARS based on telephone interview
Week 42-43 after allocation
Client Satisfaction Questionnaire
Time Frame: Week 43
8-item validated questionnaire, web-based
Week 43
Patient Evaluation of Group Therapy
Time Frame: Week 19
Purpose-made questionnaire
Week 19
Group Questionnaire - brief
Time Frame: Weekly, weeks 4-19 after allocation, after session
8 items from validated questionnaire about group atmosphere
Weekly, weeks 4-19 after allocation, after session
Therapist Ratings of session methods and atmosphere
Time Frame: Weekly, weeks 4-19 after allocation, after session
Purpose-made questionnaire
Weekly, weeks 4-19 after allocation, after session
Homework and Event Tracker
Time Frame: Weekly, weeks 4-19 after allocation, before session
Purpose-made question for patients about homework and events previous week
Weekly, weeks 4-19 after allocation, before session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sidse MH Arnfred, MD,PhD,DMSc, Universityhospital Copenhagen, Psychiatry West, Mental Health Services Region Zealand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (ACTUAL)

April 11, 2019

Study Completion (ACTUAL)

December 11, 2019

Study Registration Dates

First Submitted

October 25, 2016

First Submitted That Met QC Criteria

November 1, 2016

First Posted (ESTIMATE)

November 3, 2016

Study Record Updates

Last Update Posted (ACTUAL)

September 16, 2020

Last Update Submitted That Met QC Criteria

September 15, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets generated by the planned study will not be publicly available due to the rules of the Danish Data Protection Agency, but will be available from the corresponding author, after publication, on reasonable request and following signed confidentiality agreement with PI and the Danish Data Protection Agency Region Zealand.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Panic Disorder

Clinical Trials on UP-CBT

3
Subscribe